Life cycle management of analytical methods
暂无分享,去创建一个
[1] Evelien Wynendaele,et al. Surface acoustic wave biosensor as a functional-quality method in pharmaceutics , 2015 .
[2] Yvan Vander Heyden,et al. Prediction of peptide retention at different HPLC conditions from multiple linear regression models. , 2005, Journal of proteome research.
[3] Ramalingam Peraman,et al. Analytical Quality by Design: A Tool for Regulatory Flexibility and Robust Analytics , 2015, International journal of analytical chemistry.
[4] P. Haddad,et al. Prediction of retention in hydrophilic interaction liquid chromatography using solute molecular descriptors based on chemical structures. , 2017, Journal of chromatography. A.
[5] Karl Fraser,et al. Predicting retention time in hydrophilic interaction liquid chromatography mass spectrometry and its use for peak annotation in metabolomics , 2014, Metabolomics.
[6] Jane Weitzel,et al. Establishment of Measurement Requirements – Analytical Target Profile and Decision Rules , 2014 .
[7] X. Yang,et al. Quality by design (QbD) based development of a stability indicating HPLC method for drug and impurities. , 2011, Journal of chromatographic science.
[8] K. Unger,et al. Reverse-phase ion-pair chromatography of polyvalent ions using oligonucleotides as model substances. , 1982, Analytical biochemistry.
[9] T. Schofield,et al. Application of an innovative design space optimization strategy to the development of liquid chromatographic methods to combat potentially counterfeit nonsteroidal anti-inflammatory drugs. , 2012, Journal of chromatography. A.
[10] Christopher Singleton,et al. Recent advances in bioanalytical sample preparation for LC-MS analysis. , 2012, Bioanalysis.
[11] Abdelmjid Abourriche,et al. Statistical tools and approaches to validate analytical methods: methodology and practical examples , 2017 .
[12] Ana Stajić,et al. Quality by Design in the development of hydrophilic interaction liquid chromatography method with gradient elution for the analysis of olanzapine , 2017, Journal of pharmaceutical and biomedical analysis.
[13] I. Krull,et al. A Quality-by-Design Methodology for Rapid LC Method Development, Part III , 2008 .
[14] Tong-Yuan Yang,et al. Characterization of critical reagents in ligand-binding assays: enabling robust bioanalytical methods and lifecycle management. , 2013, Bioanalysis.
[15] René P Schwarzenbach,et al. Identification of transformation products of organic contaminants in natural waters by computer-aided prediction and high-resolution mass spectrometry. , 2009, Environmental science & technology.
[16] H. Wätzig,et al. Application of the equivalence test according to a concept for analytical method transfers from the International Society for Pharmaceutical Engineering (ISPE). , 2005, Journal of pharmaceutical and biomedical analysis.
[17] Joachim Ermer,et al. Method Validation in Pharmaceutical Analysis : A Guide to Best Practice , 2014 .
[18] R. Marini,et al. Application of an innovative design space optimization strategy to the development of LC methods for the simultaneous screening of antibiotics to combat poor quality medicines. , 2013, Journal of pharmaceutical and biomedical analysis.
[19] J Ermer,et al. Validation in pharmaceutical analysis. Part I: an integrated approach. , 2001, Journal of pharmaceutical and biomedical analysis.
[20] M. Jovanović,et al. Quality by Design approach in the development of hydrophilic interaction liquid chromatographic method for the analysis of iohexol and its impurities. , 2015, Journal of pharmaceutical and biomedical analysis.
[21] C. Mant,et al. Prediction of peptide retention times in reversed-phase high-performance liquid chromatography II. Correlation of observed and predicted peptide retention times factors and influencing the retention times of peptides , 1986 .
[22] I. Molnár,et al. Aspects of the "Design Space" in high pressure liquid chromatography method development. , 2010, Journal of chromatography. A.
[23] Steven M Cramer,et al. Investigation of protein binding affinity and preferred orientations in ion exchange systems using a homologous protein library , 2009, Biotechnology and bioengineering.
[24] M. W. Dong,et al. Handbook Of Pharmaceutical Analysis By Hplc , 2008 .
[25] U. Urleb,et al. Quality by design based optimization of a high performance liquid chromatography method for assay determination of low concentration preservatives in complex nasal formulations. , 2015, Acta chimica Slovenica.
[26] J. Veuthey,et al. Computer assisted liquid chromatographic method development for the separation of therapeutic proteins. , 2016, The Analyst.
[27] P. Haddad,et al. Performance comparison of partial least squares-related variable selection methods for quantitative structure retention relationships modelling of retention times in reversed-phase liquid chromatography. , 2015, Journal of chromatography. A.
[28] J. Ermer,et al. The transfer of analytical procedures. , 2013, Journal of pharmaceutical and biomedical analysis.
[29] T. Madrakian,et al. Nanomaterials as sorbents for sample preparation in bioanalysis: A review. , 2017, Analytica chimica acta.
[30] Douglas Both,et al. Analytical Method Quality by Design for an On-Line Near-Infrared Method to Monitor Blend Potency and Uniformity , 2014, Journal of Pharmaceutical Innovation.
[31] S. Hansen,et al. Bioanalysis of pharmaceuticals : sample preparation, separation techniques, and mass spectrometry , 2015 .
[32] P. Kulhánek,et al. Sequence-dependent separation of trinucleotides by ion-interaction reversed-phase liquid chromatography-A structure-retention study assisted by soft-modelling and molecular dynamics. , 2016, Journal of chromatography. A.
[33] N. Etxebarria,et al. Improvement of the chromatographic separation of several 1,4-dihydropyridines calcium channel antagonist drugs by experimental design. , 2005, Journal of chromatographic science.
[34] Emma L. Schymanski,et al. Identifying small molecules via high resolution mass spectrometry: communicating confidence. , 2014, Environmental science & technology.
[35] E. Wynendaele,et al. An analytical quality by design (aQbD) approach for a L-asparaginase activity method. , 2016, Journal of pharmaceutical and biomedical analysis.
[36] J. Loco,et al. Calculation of the decision limit (CCalpha) and the detection capability (CCbeta) for banned substances: the imperfect marriage between the quantitative and the qualitative criteria. , 2007, Analytica chimica acta.
[37] Alexander H Schmidt. Development of an HPLC Method for the Determination of Hydroxycinnamic Acid Derivatives in Cimicifuga racemosa (Black Cohosh) Extracts Using an Automated Method Development System , 2005 .
[38] B. Nickerson. Sample Preparation of Pharmaceutical Dosage Forms , 2011 .
[39] L. Snyder,et al. Selectivity differences for C18 and C8 reversed-phase columns as a function of temperature and gradient steepness. I. Optimizing selectivity and resolution. , 2000, Journal of chromatography. A.
[40] L. T. Taylor,et al. The use of supercritical fluid extraction for sample preparation of pharmaceutical formulations. , 1997, Journal of pharmaceutical and biomedical analysis.
[41] Andrea Armirotti,et al. Kernel-Based, Partial Least Squares Quantitative Structure-Retention Relationship Model for UPLC Retention Time Prediction: A Useful Tool for Metabolite Identification. , 2016, Analytical chemistry.
[42] Milton L. Lee,et al. Sub-2 μm porous and nonporous particles for fast separation in reversed-phase high performance liquid chromatography , 2006 .
[43] Imre Molnar,et al. Computerized design of separation strategies by reversed-phase liquid chromatography: development of DryLab software. , 2002, Journal of chromatography. A.
[44] Siegfried Wartewig,et al. Pharmaceutical applications of Mid-IR and Raman spectroscopy. , 2005, Advanced drug delivery reviews.
[45] G. Murkitt,et al. Sample preparation for the HPLC analysis of drugs in biological fluids. , 1989, Journal of pharmaceutical and biomedical analysis.
[46] A. Alexander,et al. A stepwise strategy employing automated screening and DryLab modeling for the development of robust methods for challenging high performance liquid chromatography separations: a case study. , 2011, Analytica chimica acta.
[47] Janusz Pawliszyn,et al. Quantitative structure-retention relationships models for prediction of high performance liquid chromatography retention time of small molecules: endogenous metabolites and banned compounds. , 2013, Analytica chimica acta.
[48] Alexander H. Schmidt,et al. Computer-assisted optimization in the development of a high-performance liquid chromatographic method for the analysis of kava pyrones in Piper methysticum preparations. , 2002, Journal of chromatography. A.
[49] Bhupinder Singh,et al. Systematic Development and Validation of a Thin-Layer Densitometric Bioanalytical Method for Estimation of Mangiferin Employing Analytical Quality by Design (AQbD) Approach. , 2016, Journal of chromatographic science.
[50] Simon J. Bale,et al. Quality by Design for Analytical Methods , 2010 .
[51] Ian D Wilson,et al. An overview of fecal sample preparation for global metabolic profiling. , 2015, Journal of pharmaceutical and biomedical analysis.
[52] Joachim Ermer,et al. Validation in pharmaceutical analysis. Part II: Central importance of precision to establish acceptance criteria and for verifying and improving the quality of analytical data. , 2005, Journal of pharmaceutical and biomedical analysis.
[53] STIMULI TO THE REVISION PROCESS , 2017 .
[54] C. López-Morales,et al. Design of a strong cation exchange methodology for the evaluation of charge heterogeneity in glatiramer acetate , 2017, Journal of pharmaceutical and biomedical analysis.
[55] Peter W Carr,et al. The Hydrophobic-Subtraction Model of Reversed-Phase Column Selectivity. , 2012, Advances in chromatography.
[56] David G. Holcombe,et al. A life cycle approach to method management , 2001 .
[57] M. Swartz. Ultra performance liquid chromatography (UPLC) : An introduction , 2005 .
[58] Lubertus Bijlsma,et al. Critical evaluation of a simple retention time predictor based on LogKow as a complementary tool in the identification of emerging contaminants in water. , 2015, Talanta.
[59] Ich Harmonised,et al. INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE , 2006 .
[60] L. Snyder,et al. The Linear-Solvent-Strength Model of Gradient Elution , 1998 .
[61] Jelena Terzić,et al. Application of Analytical Quality by Design concept for bilastine and its degradation impurities determination by hydrophilic interaction liquid chromatographic method. , 2016, Journal of pharmaceutical and biomedical analysis.
[62] R. Plumb,et al. Comprehensive investigation of the influence of acidic, basic, and organic mobile phase compositions on bioanalytical assay sensitivity in positive ESI mode LC/MS/MS. , 2012, Journal of pharmaceutical and biomedical analysis.
[63] M. Swartz,et al. New frontiers in chromatography , 2005 .
[64] R. Marini,et al. Combination of partial least squares regression and design of experiments to model the retention of pharmaceutical compounds in supercritical fluid chromatography. , 2017, Journal of chromatography. A.
[65] Thomas Letzel,et al. Non-target screening with high-resolution mass spectrometry: critical review using a collaborative trial on water analysis , 2015, Analytical and Bioanalytical Chemistry.
[66] H. C. Bertram,et al. Time-saving design of experiment protocol for optimization of LC-MS data processing in metabolomic approaches. , 2013, Analytical chemistry.
[67] M. Ibáñez,et al. UHPLC-QTOF MS screening of pharmaceuticals and their metabolites in treated wastewater samples from Athens. , 2017, Journal of hazardous materials.
[68] A. Pelander,et al. Prediction of liquid chromatographic retention for differentiation of structural isomers. , 2012, Analytica chimica acta.
[69] V. Samanidou,et al. Green approaches in sample preparation of bioanalytical samples prior to chromatographic analysis. , 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[70] R. Bro,et al. Near-infrared chemical imaging (NIR-CI) on pharmaceutical solid dosage forms-comparing common calibration approaches. , 2008, Journal of pharmaceutical and biomedical analysis.
[71] Leon P Barron,et al. Prediction of chromatographic retention time in high-resolution anti-doping screening data using artificial neural networks. , 2013, Analytical chemistry.
[72] X. Yang,et al. Quality by design (QbD) based development and validation of an HPLC method for amiodarone hydrochloride and its impurities in the drug substance. , 2014, Journal of pharmaceutical and biomedical analysis.
[73] Joachim Ermer,et al. Analytical Validation within the Pharmaceutical Lifecycle , 2014 .
[74] Y. Heyden,et al. Support Vector Regression Based QSPR for the Prediction of Retention Time of Peptides in Reversed-Phase Liquid Chromatography , 2014, Chromatographia.
[75] S Furlanetto,et al. An integrated quality by design and mixture-process variable approach in the development of a capillary electrophoresis method for the analysis of almotriptan and its impurities. , 2014, Journal of chromatography. A.
[76] G. L. Reid,et al. REVERSED-PHASE LIQUID CHROMATOGRAPHIC METHOD DEVELOPMENT IN AN ANALYTICAL QUALITY BY DESIGN FRAMEWORK , 2013 .
[77] Lloyd R. Snyder,et al. Practical HPLC method development , 1988 .
[78] J. R. Torres-Lapasió,et al. Models and objective functions for the optimisation of selectivity in reversed-phase liquid chromatography. , 2006, Analytica chimica acta.
[79] P. Haddad,et al. Towards a chromatographic similarity index to establish localized quantitative structure-retention models for retention prediction: Use of retention factor ratio. , 2017, Journal of chromatography. A.
[80] Melissa D'Archangelo. Flow cytometry: New guidelines to support its clinical application , 2007, Cytometry. Part B, Clinical cytometry.
[81] Edward Tabler,et al. Validation and life-cycle management of a quantitative ligand-binding assay for the measurement of Nulojix(®), a CTLA-4-Fc fusion protein, in renal and liver transplant patients. , 2012, Bioanalysis.
[82] Cyrus Agarabi,et al. Application of quality by design elements for the development and optimization of an analytical method for protamine sulfate. , 2012, Journal of pharmaceutical and biomedical analysis.
[83] S. L Kiprotich. An insight on international conference of harmonisation of technical requirements for registration of pharmaceutical products for human use (ICH). , 2009 .
[84] C. Frömke,et al. Analytical method transfer: improving interpretability with ratio-based statistical approaches. , 2013, Journal of pharmaceutical and biomedical analysis.
[85] H. Wätzig,et al. Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010). , 2006, Journal of pharmaceutical and biomedical analysis.
[86] Michael E. Swartz,et al. UPLC TM : An Introduction and Review , 2005 .
[87] Evsevios Hadjicostas,et al. Validation of Analytical Methods – to be Fit for the Purpose , 2010 .
[88] C. Breneman,et al. Prediction of protein retention in ion-exchange systems using molecular descriptors obtained from crystal structure. , 2001, Analytical chemistry.
[89] Enrique Carredano,et al. Electrostatic calculations and quantitative protein retention models for ion exchange chromatography. , 2006, Journal of chromatography. A.
[90] Sam H Haidar,et al. 2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 - LBA, biomarkers and immunogenicity). , 2016, Bioanalysis.
[91] Slobodan ai,et al. Pharmaceutical Applications of Raman Spectroscopy , 2007 .
[92] J. Veuthey,et al. Fast analysis in liquid chromatography using small particle size and high pressure. , 2006, Journal of separation science.
[93] Michael E. Swartz,et al. UPLC™: An Introduction and Review , 2005 .
[94] Sophie Vaslin-Reimann,et al. Estimating sampling and analysis uncertainties to assess the fitness for purpose of a water quality monitoring network , 2016, Accreditation and Quality Assurance.
[95] Bertil Magnusson,et al. The Fitness for Purpose of Analytical Methods , 2014 .
[96] Michael Thompson,et al. Harmonized guidelines for single-laboratory validation of methods of analysis (IUPAC Technical Report) , 2002 .
[97] Lubertus Bijlsma,et al. Suspect screening of large numbers of emerging contaminants in environmental waters using artificial neural networks for chromatographic retention time prediction and high resolution mass spectrometry data analysis. , 2015, The Science of the total environment.
[98] O. Svensson,et al. A quality control method enhancement concept-Continual improvement of regulatory approved QC methods. , 2016, Journal of pharmaceutical and biomedical analysis.
[100] Alessandro Morais Saviano,et al. Measurement uncertainty in pharmaceutical analysis and its application , 2013, Journal of pharmaceutical analysis.
[101] Michael W. Dong,et al. Modern HPLC for Practicing Scientists , 2006 .
[102] T. Hanai,et al. Optimization of retention time of aromatic acids in liquid chromatography from log P and predicted pKa values , 1984 .
[103] K. Gaudin,et al. Using an innovative combination of quality-by-design and green analytical chemistry approaches for the development of a stability indicating UHPLC method in pharmaceutical products. , 2015, Journal of pharmaceutical and biomedical analysis.
[104] Benjamin Debrus,et al. New methodology for the development of chromatographic methods with bioanalytical application. , 2011, Bioanalysis.
[105] Philippe Hubert,et al. Screening study of SFC critical method parameters for the determination of pharmaceutical compounds. , 2016, Journal of pharmaceutical and biomedical analysis.
[106] Gillian L McEneff,et al. Gradient liquid chromatographic retention time prediction for suspect screening applications: A critical assessment of a generalised artificial neural network-based approach across 10 multi-residue reversed-phase analytical methods. , 2016, Talanta.
[107] R. Plackett,et al. THE DESIGN OF OPTIMUM MULTIFACTORIAL EXPERIMENTS , 1946 .
[108] Olaf H Drummer,et al. Validation of new methods. , 2007, Forensic science international.
[109] Pierre Lebrun,et al. Application of design space optimization strategy to the development of LC methods for simultaneous analysis of 18 antiretroviral medicines and 4 major excipients used in various pharmaceutical formulations , 2017, Journal of pharmaceutical and biomedical analysis.
[110] Alban Arrault,et al. UPLC–MS retention time prediction: a machine learning approach to metabolite identification in untargeted profiling , 2015, Metabolomics.
[111] Darko Ivanović,et al. Comparison of Full Factorial Design, Central Composite Design, and Box-Behnken Design in Chromatographic Method Development for the Determination of Fluconazole and Its Impurities , 2014 .
[112] A. Squirrell,et al. Eurachem/CITAC Guide - Use of Uncertainty Information in Compliance Assessment, 1st edn. , 2015 .
[113] M. Jovanović,et al. THEORETICAL AND EMPIRICAL MODELS IN HYDROPHILIC INTERACTION LIQUID CHROMATOGRAPHY , 2014 .
[114] J. Dolan,et al. Selectivity differences for C18 and C8 reversed-phase columns as a function of temperature and gradient steepness. II. Minimizing column reproducibility problems. , 2000, Journal of chromatography. A.
[115] R. Marini,et al. Optimization and validation of a fast supercritical fluid chromatography method for the quantitative determination of vitamin D3 and its related impurities. , 2017, Journal of chromatography. A.
[116] Joseph Moses Juran. Juran on Quality by Design: The New Steps for Planning Quality into Goods and Services , 1992 .
[117] Valeri I. Babushok,et al. Retention Characteristics of Peptides in RP-LC: Peptide Retention Prediction , 2010 .
[118] I. Molnár,et al. Using an innovative Quality-by-Design approach for development of a stability indicating UHPLC method for ebastine in the API and pharmaceutical formulations. , 2013, Journal of pharmaceutical and biomedical analysis.
[119] Andreas Zell,et al. Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. , 2013, Clinical chemistry.
[120] I. Apostol,et al. Comparison of different approaches for evaluation of the detection and quantitation limits of a purity method: a case study using a capillary isoelectrofocusing method for a monoclonal antibody. , 2009, Analytical biochemistry.
[121] M. Swartz. 6 Contemporary liquid chromatographic systems for method development , 2007 .
[122] Ana Vemić,et al. Development of liquid chromatographic method for the analysis of dabigatran etexilate mesilate and its ten impurities supported by quality-by-design methodology. , 2015, Journal of pharmaceutical and biomedical analysis.
[123] Roman Szucs,et al. Evaluation of ultra performance liquid chromatography. Part I. Possibilities and limitations. , 2006, Journal of chromatography. A.
[124] L. Snyder,et al. Computer-assisted method development for high performance liquid chromatography: Elsevier, Amsterdam, 1990 (ISBN 0-444-88748-2). xxiv + 682 pp. Price Dfl. 175.00/US $ 79.75 , 1991 .
[125] A. Oberg,et al. Optimizing Mass Spectrometry Analyses: A Tailored Review on the Utility of Design of Experiments , 2016, Journal of The American Society for Mass Spectrometry.
[126] Tsuyoshi Murata,et al. {m , 1934, ACML.
[127] G. L. Reid,et al. No Sample Preparation , 2011 .
[128] Yimin Hua,et al. A platform analytical quality by design (AQbD) approach for multiple UHPLC-UV and UHPLC-MS methods development for protein analysis. , 2016, Journal of pharmaceutical and biomedical analysis.
[129] Davy Guillarme,et al. Newer Developments in HPLC Impacting Pharmaceutical Analysis : A Brief Review , 2013 .
[130] P. Haddad,et al. Towards a chromatographic similarity index to establish localised quantitative structure-retention relationships for retention prediction. II Use of Tanimoto similarity index in ion chromatography. , 2017, Journal of chromatography. A.
[132] Reza Aalizadeh,et al. Quantitative Structure-Retention Relationship Models To Support Nontarget High-Resolution Mass Spectrometric Screening of Emerging Contaminants in Environmental Samples , 2016, J. Chem. Inf. Model..
[133] Gongke Li,et al. Magnetic separation techniques in sample preparation for biological analysis: a review. , 2014, Journal of pharmaceutical and biomedical analysis.
[134] P. Hubert,et al. Improvement of a stability-indicating method by Quality-by-Design versus Quality-by-Testing: a case of a learning process. , 2014, Journal of pharmaceutical and biomedical analysis.
[135] S. Rudaz,et al. Improved quality-by-design compliant methodology for method development in reversed-phase liquid chromatography. , 2013, Journal of pharmaceutical and biomedical analysis.
[136] R. Breitling,et al. Toward global metabolomics analysis with hydrophilic interaction liquid chromatography-mass spectrometry: improved metabolite identification by retention time prediction. , 2011, Analytical chemistry.
[137] G. Somsen,et al. One single, fast and robust capillary electrophoresis method for the direct quantification of intact adenovirus particles in upstream and downstream processing samples. , 2017, Talanta.
[139] C. West,et al. Deconvoluting the effects of buffer salt concentration in hydrophilic interaction chromatography on a zwitterionic stationary phase. , 2016, Journal of chromatography. A.
[140] Y. B. Chavan. LIFE CYCLE ASSESSMENT (LCA) APPROACH TO ANALYTICAL METHOD DEVELOPMENT: A REVIEW , 2015 .
[141] Ming Yan,et al. Validation of cell‐based fluorescence assays: Practice guidelines from the ICSH and ICCS – part V – assay performance criteria , 2013, Cytometry. Part B, Clinical cytometry.
[142] Hermann Wätzig,et al. Efficient and economic HPLC performance qualification. , 2010, Journal of pharmaceutical and biomedical analysis.
[143] Muriel Noetzli,et al. Simultaneous determination of antidementia drugs in human plasma: procedure transfer from HPLC-MS to UPLC-MS/MS. , 2012, Journal of pharmaceutical and biomedical analysis.
[144] S. Furlanetto,et al. Quality by design in the chiral separation strategy for the determination of enantiomeric impurities: development of a capillary electrophoresis method based on dual cyclodextrin systems for the analysis of levosulpiride. , 2015, Journal of chromatography. A.
[145] E. Chan,et al. Applications of monolithic materials for sample preparation. , 2014, Journal of pharmaceutical and biomedical analysis.
[146] I. Molnár,et al. Quality by Design: Multidimensional exploration of the design space in high performance liquid chromatography method development for better robustness before validation. , 2012, Journal of chromatography. A.
[147] Flavia Ruggieri,et al. Full validation and accreditation of a method to support human biomonitoring studies for trace and ultra-trace elements , 2016 .
[148] S. A. White,et al. Evaluation of ultra-performance liquid chromatography in the bioanalysis of small molecule drug candidates in plasma. , 2007, Journal of chromatographic science.
[149] Joachim Ermer,et al. Transfer of Analytical Procedures , 2005 .
[150] Roman Kaliszan,et al. Predictions of peptides' retention times in reversed‐phase liquid chromatography as a new supportive tool to improve protein identification in proteomics , 2009, Proteomics.
[151] Bernard A Olsen,et al. A quality by design approach to impurity method development for atomoxetine hydrochloride (LY139603). , 2008, Journal of pharmaceutical and biomedical analysis.
[152] R. L. Baglow. The reliability parameter and its importance for life cycle management , 1975 .
[153] Serge Rudaz,et al. Prediction of retention time in reversed-phase liquid chromatography as a tool for steroid identification. , 2016, Analytica chimica acta.
[154] I. Molnár,et al. From Csaba Horváth to Quality by Design: Visualizing Design Space in Selectivity Exploration of HPLC Separations , 2011 .
[155] Thorsten Verch,et al. Quality by design for a vaccine release immunoassay: a case study. , 2013, Bioanalysis.
[156] Wojciech Szpankowski,et al. Uncertainty Estimates of Purity Measurements Based on Current Information: Toward a “Live Validation” of Purity Methods , 2012, Pharmaceutical Research.
[157] J. Mazzeo,et al. A new separation technique takes advantage of suh-2-μm porous particles , 2005 .
[158] G. L. Reid,et al. Quantitative Structure Retention Relationship Models in an Analytical Quality by Design Framework: Simultaneously Accounting for Compound Properties, Mobile-Phase Conditions, and Stationary-Phase Properties , 2013 .
[159] H. Verelst,et al. Future of high pressure liquid chromatography: do we need porosity or do we need pressure? , 2006, Journal of chromatography. A.
[160] L A Larew,et al. Statistical approaches to determine analytical variability and specifications: application of experimental design and variance component analysis. , 1998, Journal of pharmaceutical and biomedical analysis.